Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 1,200 JAZZ shares, $289.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 1,200 | $289.1K |
| Jul 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 2,678 | $636.6K |
| Jun 12, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 1,200 | $278.2K |
| Jun 1, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 1,192 | $282.5K |
| May 20, 2026 | TELEFLEX INC (TFX) | Grant/Award | 1,090 | n/a |
| Mar 9, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 5,000 | $943.5K |
| Mar 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Exercise/Conversion | 20,125 | $2.28M |
| Jan 22, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 8,852 | n/a |
| May 13, 2025 | TELEFLEX INC (TFX) | Grant/Award | 1,051 | n/a |
| Mar 7, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to Issuer | 4,088 | $568.0K |